Latest News and Press Releases
Want to stay updated on the latest news?
-
PHILADELPHIA, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Avantor, Inc. (NYSE: AVTR): Grabar Law Office is investigating claims on behalf of shareholders of Avantor, Inc. (NYSE: AVTR). The investigation...
-
PHILADELPHIA, Nov. 09, 2025 (GLOBE NEWSWIRE) -- Avantor, Inc. (NYSE: AVTR): Grabar Law Office is investigating claims on behalf of shareholders of Avantor, Inc. (NYSE: AVTR). The investigation...
-
PHILADELPHIA, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Grabar Law Office is investigating claims on behalf of shareholders of Maison Solutions Inc. (NASDAQ: MSS) as an underlying securities fraud class...
-
PHILADELPHIA, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) - Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
-
PHILADELPHIA, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Grabar Law Office is investigating claims on behalf of shareholders of Maison Solutions Inc. (NASDAQ: MSS) as an underlying securities fraud class...
-
PHILADELPHIA, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Avantor, Inc. (NYSE: AVTR): Grabar Law Office is investigating claims on behalf of shareholders of Avantor, Inc. (NYSE: AVTR). The investigation...
-
PHILADELPHIA, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Avantor, Inc. (NYSE: AVTR): Grabar Law Office is investigating claims on behalf of shareholders of Avantor, Inc. (NYSE: AVTR). The...
-
PHILADELPHIA, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Avantor, Inc. (NYSE: AVTR): Grabar Law Office is investigating claims on behalf of shareholders of Avantor, Inc. (NYSE: AVTR). The investigation...
-
PHILADELPHIA, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
-
PHILADELPHIA, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Five Below, Inc. (NASDAQ: FIVE) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of...